TABLE 1.

Demographic and Clinical Characteristics of 23 Healthy Controls and 21 Patients With Cirrhosis

	Healthy Controls (n = 23)	Patients With Cirrhosis (n = 21)
Age (years)	49.3 ± 15.2	56.8 ± 10.7
Ethnicity, n (%)
White	20 (87%)	20 (95%)
Black	1 (4%)	0 (0%)
Other	2 (9%)	1 (5%)
Etiology, n (%)
Alcohol	—	12 (57%)
NAFLD	—	6 (29%)
HCV	—	3 (14%)
Other	—	4 (19%)
Clinical characteristics
AD	—	6 (29%)
ACLF	—	15 (71%)
Ascites	—	15 (71%)
SBP	—	4 (19%)
DM	—	5 (24%)
Renal replacement therapy	—	4 (19%)
Candida colonization	—	4 (19%)
Medications, n (%)
Beta‐blockers	2 (9%)	3 (14%)
Furosemide	0	4 (19%)
Octreotide	0	5 (24%)
PPI	0	15 (71%)
Lactulose	0	15 (71%)
Rifaximin	0	16 (76%)

Data are presented as mean ± SD or number (percentage) as appropriate.

Abbreviations: ACLF, acute on chronic liver failure; AD, acute decompensated cirrhosis.